Maharashtra FDA acts against 880 drug manufacturers and retailers in compliance drive
The Maharashtra FDA conducted 2,902 inspections and acted against 880 manufacturing and drug-sales establishments, seizing illegal drugs and cosmetics worth Rs 11.41 crore. The action highlights heightened compliance risk for pharmacy retailers around prescriptions, pharmacist supervision, documentation and product quality.
What happened
Maharashtra Food and Drug Administration · Maharashtra FDA acted against 880 drug manufacturers and retailers after 2,902 inspections, citing quality,
Key facts
- 880 drug manufacturing and sales establishments acted against
- 2,902 inspections
- 607 manufacturing-unit inspections
- 2,295 drug sales establishment inspections
- 104 search and seizure operations
- Rs 11.41 crore illegal drugs and cosmetics seized
- 20 FIRs
- 21 arrests
- 140 manufacturing units acted against
- 740 sales establishments acted against
- Complaints up 557%
- Complaint investigations up 378%
- Search and seizures up 217%
- Seized stock value up 234%
- FIR registrations up 21%
Why this matters
Acquirers and partners should increase regulatory diligence on pharmacy targets in Maharashtra, with particular scrutiny of licenses, prescription practices, pharmacist staffing and inventory provenance.